From the Journals
Clinical Guidelines
Feature

AI-Selected Trial Candidates are More Diverse

Could artificial intelligence-enabled medical chart review improve the speed, accuracy, and equity of study enrollment?

  • By

  • March 10, 2026

  • 3 min

Share

  • 1

    AI system analyzed EMRs for clinical trial eligibility.

  • 2

    Focus on transthyretin amyloid cardiomyopathy.

  • 3

    Achieved 96.2% accuracy in criteria evaluation.

  • 4

    Increased diversity in trial participants (37% Black patients).

  • 5

    Automated process reduced manual workload substantially.

  • 6

    Proven reliability in filtering out ineligible patients (99% correct).

  • 7

    AI identified patients missed by traditional methods.

  • 8

    Provides traceable explanations for decision-making.

Original Source(s)

AI-Selected Trial Candidates are More Diverse

Could artificial intelligence-enabled medical chart review improve the speed, accuracy, and equity of study enrollment?

  • March 10, 2026

  • 3 min

Related Content

Cardiac Arrest Patterns After Holidays

Association strongest after multiday holidays and in several higher-risk patient groups.

Medical Oddities: The Calmest Move in Cardiology?

Yoga for SVT, romantic brain bias, dog-made air chemistry, math learning clues, selenium tea, and glaucoma pillows—medicine’s weekly roundup of strange.

Low-Dose Rivaroxaban Did Not Reduce LV Thrombus After Anterior STEMI

Adding low-dose rivaroxaban to dual antiplatelet therapy following anterior myocardial infarction did not reduce cardiac MRI–detected left ventricular thrombus at 1 month and increased minor bleeding in a 560-patient randomized trial.